Cargando…
Leveraging hybrid biomarkers in clinical endpoint prediction
BACKGROUND: Clinical endpoint prediction remains challenging for health providers. Although predictors such as age, gender, and disease staging are of considerable predictive value, the accuracy often ranges between 60 and 80%. An accurate prognosis assessment is required for making effective clinic...
Autores principales: | Saad, Maliazurina, Lee, Ik Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538849/ https://www.ncbi.nlm.nih.gov/pubmed/33028301 http://dx.doi.org/10.1186/s12911-020-01262-3 |
Ejemplares similares
-
Incorporating digitally derived endpoints within clinical development programs by leveraging prior work
por: Bertha, Amy, et al.
Publicado: (2023) -
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables
por: Jiang, Zhiwei, et al.
Publicado: (2014) -
Multi-omics integration for neuroblastoma clinical endpoint prediction
por: Francescatto, Margherita, et al.
Publicado: (2018) -
Endpoints in advanced breast cancer: methodological aspects & clinical implications
por: Saad, Everardo D.
Publicado: (2011) -
Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review
por: Al-Tashi, Qasem, et al.
Publicado: (2023)